查找临床试验
已按「神经内分泌肿瘤」检索，对应国际通用词 neuroendocrine tumor
共找到 117 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:25，每 5 分钟自动同步An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
China
年龄 18 Years – 不限
Beijing Tide Pharmaceutical Co., Ltd
Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
China
年龄 18 Years – 不限
Shanghai Kechow Pharma, Inc.
A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors
China
年龄 18 Years – 不限
Suzhou BlueHorse Therapeutics Co., Ltd.
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
United States、Argentina、Australia、Belgium、Brazil 等 12 国
年龄 18 Years – 不限
Daiichi Sankyo
Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors
China
年龄 18 Years – 不限
Mainline Biosciences (Shanghai) Co., Ltd
Study of GV20-0251 in Participants With Solid Tumor Malignancies
China
年龄 18 Years – 不限
GV20 Therapeutics
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.
China
年龄 18 Years – 75 Years
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
China
年龄 18 Years – 75 Years
Guangzhou FineImmune Biotechnology Co., LTD.
VSV-02 Compassionate Use in Advanced Solid Tumors
China
年龄 18 Years – 不限
The First Affiliated Hospital of Xinxiang Medical College
Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma
China
年龄 18 Years – 75 Years
RenJi Hospital
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
China
年龄 不限 – 不限
Essen Biotech
A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)
China
年龄 18 Years – 不限
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.